Hypoactive Sexual Desire in Men

  • Yonah Krakowsky
  • Ethan D. GroberEmail author


Hypoactive sexual desire is a common complaint in men of all ages. By recognizing different etiologies that contribute to low libido in men, clinicians can initiate a patient-centered evaluation and treatment plan. A thorough history, physical exam, and appropriate laboratory investigations can identify men with underlying medical and/or psychiatric conditions that can be addressed to improve sexual desire. Men without modifiable comorbid conditions represent a current challenge, as there are no treatments specific to male hypoactive sexual desire. As the understanding of male hypoactive sexual desire evolves, more modalities will become available for both assessment and treatment.


Hypoactive Sexual desire Males Libido 

Supplementary material


  1. 1.
    Rubio-Aurioles R. Hypoactive sexual desire on men. In: Porst H, Buvat J, The Standards Committee of the International Society for Sexual Medicine, editors. Standard practice in sexual medicine. Malden, MA: Blackwell Publishing; 2006. p. 149–57.CrossRefGoogle Scholar
  2. 2.
    Levine SB. Hypoactive sexual desire disorder in men: basic types, causes, and treatment. Psychiatr Times. 2010;27:40–3.Google Scholar
  3. 3.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.Google Scholar
  4. 4.
    Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in “normal” couples. N Engl J Med. 1978;299:111–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Laumann EO, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.CrossRefPubMedGoogle Scholar
  6. 6.
    Mercer CH, Fenton KA, Johnson AM, Wellings K, Macdowall W, McManus S, Nanchahal K, Erens B. Sexual function problems and help seeking behavior in Britain: national probability sample survey. BMJ. 2003;327:426–7.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Najman JM, Dunne MP, Boyle FM, Cook MD, Purdie DM. Sexual dysfunction in the Australian population. Aust Fam Physician. 2003;32:951–4.PubMedGoogle Scholar
  8. 8.
    Fugl-Meyer AR, Fugl-Meyer KS. Sexual disabilities, problems, and satisfactions in 18–74 year old Swedes. Scand J Sexol. 1999;2:79–105.Google Scholar
  9. 9.
    Laumann E, Glasser DB, Neves RCS, Moreira EDJ, GSSAB Investigators Group. A population-based survey of sexual activity, sexual problems and associated help seeking behavior patterns in mature adults in the United States of American. Int J Impot Res. 2009;21:171–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Bancroft J. Sexual desire and the brain. J Sex Marital Ther. 1988;3:11–27.CrossRefGoogle Scholar
  11. 11.
    Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol. 2005;63:381–94.CrossRefGoogle Scholar
  12. 12.
    Zitzman M, Farber S, Nieschlang E. Association of specific symptoms and metabolic risk with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91:4335–43.CrossRefGoogle Scholar
  13. 13.
    De Rosa M, Zarrilli S, Vitale G, Di Somma C, Orio F, Tauchmanova L, Lombardi G, Colao A. Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. J Clin Endocrinol Metab. 2004;89:621–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res. 2003;15:373–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989;12:375–83.CrossRefPubMedGoogle Scholar
  16. 16.
    Bancroft J, Janssen E, Strong D, Carnes L, Vukadinovic Z, Long JS. The relation between mood and sexuality in heterosexual men. Arch Sex Behav. 2003;32:217–30.CrossRefPubMedGoogle Scholar
  17. 17.
    Kennedy SH, Dickens SE, Eisfeld BS, Bagbya RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord. 1999;56:201–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Corona G, Petrone L, Mannucci E, Ricca V, Balercia G, Giommi R, Forti G, Maggi M. The impotent couple: low desire. Int J Androl. 2005;28:46–52.CrossRefPubMedGoogle Scholar
  19. 19.
    Casper RC, Redmond E, Katz MM, et al. Somatic symptoms in primary affective disorders: presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985;42:1098–104.CrossRefPubMedGoogle Scholar
  20. 20.
    Meuleman E, Van Lankveld J. Hypoactive sexual desire disorder: an underestimated condition in men. Presented at University Medical Centre St Radboud and Pompekliniek, Nijmegen; 12 July 2004.Google Scholar
  21. 21.
    Nilsson P, Moller L, Solstad K. Adverse effects of psychosocial stress on gonadal function and insulin levels in middle-aged males. J Intern Med. 1995;237:479–86.CrossRefPubMedGoogle Scholar
  22. 22.
    Aubin S, Berger RE, Herman JR, Ciol MA. The association between sexual function, pain, and psychological adaptation of men diagnosed with chronic pelvic pain syndrome type III. J Sex Med. 2008;5:657–67.CrossRefPubMedGoogle Scholar
  23. 23.
    Laumann EO, Nicolosi A, Glasser DB, Paik A, Ginge C, Moreira E, Wang T. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res. 2005;17:39–57.CrossRefPubMedGoogle Scholar
  24. 24.
    Schiavi RC, Rehman J. Sexuality and aging. Urol Clin N Am. 1995;22:711–26.Google Scholar
  25. 25.
    Tessler Lindau S, Schumm L, Laumann E, Levinson W, O’Muircheartaigh A, Waite L. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762–74.CrossRefGoogle Scholar
  26. 26.
    Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr. 2002;30:187–90.CrossRefPubMedGoogle Scholar
  27. 27.
    Crenshaw TL, Goldberg JP. Sexual pharmacology: drugs that affect sexual functioning. New York: W. W. Norton and Company; 1996.Google Scholar
  28. 28.
    Gutierrez MA, Stimmel GL. Management of and Counseling for psychotropic drug-induced sexual dysfunction. Pharmacotherapy. 1999;19(7):823–31. See more at
  29. 29.
    Frye CB, Berger JE. Treatment of sexual dysfunction induced by selective serotonin-reuptake inhibitors. Am J Health Syst Pharm. 1998;55:1167–9.PubMedGoogle Scholar
  30. 30.
    Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther. 1997;61:476–87.CrossRefPubMedGoogle Scholar
  31. 31.
    Guthrie SK. Clinical issues associated with maintenance treatment of patients with schizophrenia. Am J Health Syst Pharm. 2002;59 Suppl 5:S19–24.PubMedGoogle Scholar
  32. 32.
    Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry. 1989;46:275–84.CrossRefPubMedGoogle Scholar
  33. 33.
    Reis R, Goncalves A, Sakamoto A, Ferriani R, Lara L. Altered sexual and reproductive functions in epileptic men taking carbamazepine. J Sex Med. 2013;10:493–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Wincze JP, Carey MP. Sexual dysfunction: a guide for assessment and treatment. 2nd ed. New York: Guilford Press; 2001.Google Scholar
  35. 35.
    Bozman AW, Beck JG. Covariation of sexual desire and sexual arousal: the effects of anger and anxiety. Arch Sex Behav. 1991;20:47–60.CrossRefPubMedGoogle Scholar
  36. 36.
    Kaplan HS. Disorders of sexual desire. New York: Brunner/Mazel; 1979.Google Scholar
  37. 37.
    DeRogatis L, Rosen R, Goldstein I, Werneburg B, Kempthorne-Rawson J, Sand M. Characterization of hypoactive sexual desire disorder (HSDD) in men. J Sex Med. 2012;9(3):812–20.CrossRefPubMedGoogle Scholar
  38. 38.
    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.CrossRefPubMedGoogle Scholar
  39. 39.
    Spector IP, Carey MP, Steinberg L. The sexual desire inventory: development, factor structure, and evidence of reliability. J Sex Marital Ther. 1996;22:175–90.CrossRefPubMedGoogle Scholar
  40. 40.
    Clayton AH, Goldfischer ER, Goldstein I, DeRogatis L, Lewis-D’Agostino DJ, Pyke R. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med. 2009;6:730–8.CrossRefPubMedGoogle Scholar
  41. 41.
    American Association of Clinical Endocrinologist. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple’s problem—2003 update. Endocr Pract. 2003;9:77–95.CrossRefGoogle Scholar
  42. 42.
    Masters WH, Johnson VE. Human sexual response. Boston: Little, Brown and Co.; 1966.Google Scholar
  43. 43.
    Trudel G, Marchand A, Ravart M, et al. The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sex Relat Ther. 2001;16:145–64.CrossRefGoogle Scholar
  44. 44.
    Morales A, Heaton JP. Hormonal erectile dysfunction. Evaluation and management. Urol Clin N Am. 2001;28:279–88.CrossRefGoogle Scholar
  45. 45.
    O’Carroll R, Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry. 1984;145:146–51.CrossRefPubMedGoogle Scholar
  46. 46.
    Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ. Metabolic and behavioral effects of high-dose exogenous testosterone in healthy men. J Clin Endocrinol Metab. 1994;79:561–7.PubMedGoogle Scholar
  47. 47.
    Bloch M, Meiboom H, Zaig I, Schreiber S, Abramov L. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differenced. Eur Neuropsychopharmacol. 2013;239(8):910–8.CrossRefGoogle Scholar
  48. 48.
    Segraves R, Clayton A, Croft H, et al. Bupropion sustained release for the treatment of sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;3:339–42.CrossRefGoogle Scholar
  49. 49.
    Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): results from a randomized withdrawal trial. J Sex Med. 2011;8(11):3160–72.CrossRefPubMedGoogle Scholar
  50. 50.
    Fabre LF, Brown CS, Smith LC, Derogatis LR. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women. J Sex Med. 2011;8:1411–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Fabre L, Clayton A, Smith L, Goldstein I, Derogatis L. The effect of Gepirone-ER in the treatment of sexual dysfunction in depressed men. J Sex Med. 2012;9:821–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Division of Urology, Department of SurgeryUniversity of TorontoTorontoCanada
  2. 2.Division of Urology, Department of SurgeryMount Sinai and Women’s College Hospital, University of TorontoTorontoCanada

Personalised recommendations